Role of dihydropyridine calcium channel blockers in coronary bypass surgery using the radial artery graft
https://doi.org/10.15829/1560-4071-2022-4744
Abstract
Aim. To assess the effect of a pharmacological protocol for the prevention of radial artery spasm, which is based on the systemic and local use of dihydropyridine calcium channel blockers, on the long-term outcomes of autoarterial coronary artery bypass grafting.
Material and methods. According to the protocol, oral nifedipine at a dose of 5 mg/day is prescribed 3 days before surgery. Then, after the radial artery is isolated, the vessel is preserved in a solution of nifedipine (adalat) until it is used. After releasing the clamp from the aorta, a nifedipine (adalat) is infused intravenously at a dose of 0,63 mg/h. In the postoperative period, the infusion of nifedipine continues for 6 hours. In the future, patients are recommended to take dihydropyridine calcium channel blockers at a dose of 5 mg/day after discharge from the hospital.
Results. The use of the pharmacological protocol (n=225) is associated with a lower number of major cardiovascular events (mortality, myocardial infarction, stroke) compared with the control group (n=230) (9,3% and 15,7%, p=0,031) during the 5-year follow-up. This result was achieved mainly by reducing the incidence of myocardial infarction (6,2% and 12,6%, p=0,018). Also, the use of the pharmacological protocol led to a decrease in repeated revascularizations (4,4% and 16,1%, p=0,0001) compared with the control group.
Conclusion. The use of a pharmacological protocol for the prevention of radial artery spasm based on the systemic use of dihydropyridine calcium channel blockers improves the long-term outcomes of autoarterial coronary artery bypass grafting.
About the Authors
V. V. ZatolokinRussian Federation
Tomsk
Competing Interests:
none
Yu. Yu. Vechersky
Russian Federation
Tomsk
Competing Interests:
none
D. V. Manvelyan
Russian Federation
Tomsk
Competing Interests:
none
B. N. Kozlov
Russian Federation
Tomsk
Competing Interests:
none
References
1. Torregrossa G, Amabile A, Williams EE, et al. Multi-arterial and total-arterial coronary revascularization: Past, present, and future perspective. J Card Surg. 2020;35:1072-81. doi:10.1111/jocs.14537.
2. Taggart DP. The Role of Multiple Arterial Grafts in CABG: All Roads Lead to ROMA. J Am Coll Cardiol. 2019;7418:2249-53. doi:10.1016/j.jacc.2019.09.016.
3. Ambrus N, Szolnoky J, Pollesello P, et al. Prolonged antispasmodic effect in isolated radial artery graft and pronounced platelet inhibition induced by the inodilator drug, levosimendan. Basic Clin Pharmacol Toxicol. 2012;110:269-74. doi:10.1111/j.1742-7843.2011.00801.x.
4. Achouha P, Isselmoua KO, Boutekadjirtb R, et al. Reappraisal of a 20-year experience with the radial artery as a conduit for coronary bypass grafting. Eur J Cardiothorac Surg. 2012;41:87-92. doi:10.1016/j.ejcts.2011.05.027.
5. Gaudino M, Benedetto U, Fremes SE, et al. Effect of Calcium-Channel Blocker Therapy on Radial Artery Grafts After Coronary Bypass Surgery. J Am Coll Cardiol. 2019;73:2299-306. doi:10.1016/j.jacc.2019.02.054.
6. Shipulin VM, Kozlov BN, Nasrashvili GG, et al. Intraoperative chlorpromazine treatment for prevention of radial artery spasm in aortocoronary bypass grafting. Interactive CardioVascular and Thoracic Surgery. 2017;25(3):493-495. doi:10.1093/icvts/ivx143.
7. Zatolokin VV, Vechersky YuYu, Andreev SL. Pharmacological protocol for the prevention of radial artery spasm. Siberian Medical Journal. 2013;3:52-4. (In Russ.)
8. He GW. Arterial grafts: clinical classification and pharmacological management. Ann Cardiothorac Surg. 2013;2:507-18. doi:10.3978/j.issn.2225-319X.2013.07.12.
9. Tranbaugh RF, Dimitrova KR, Lucido DJ, et al. The second best arterial graft: a propensity analysis of the radial artery versus the free right internal thoracic artery to bypass the circumflex coronary artery. J Thorac Cardiovasc Surg. 2014;47:133-40. doi:10.1016/j.jtcvs.2013.08.040.
10. Aronov DM, Lupanov VP. Antagonists are collected bypassing patients with cardiovascular diseases. Focus on amlodipine. Russian medical journal. 2007;4;275-8. (In Russ.)
11. Schwann TA, Gaudino M, Baldawi M. Optimal management of radial artery grafts in CABG: Patient and target vessel selection and anti-spasm therapy. J Card Surg. 2018;5:205-12. doi:10.1111/jocs.13517.
12. Rehman SM, Yi G, Taggart DP. The radial artery: current concepts on its use in coronary artery revascularization. Ann Thorac Surg. 2013;96:1900-9. doi:10.1016/j.athoracsur.2013.06.083.
13. He GW, Taggart DP. Spasm in Arterial Grafts in Coronary Artery Bypass Grafting Surgery. Ann Thorac Surg. 2016;101:1222-9. doi:10.1016/j.athoracsur.2015.09.071.
14. Shavadia J, Norris CM, Graham MM, et al. Symptomatic graft failure and impact on clinical outcome after coronary artery bypass grafting surgery: results from the Alberta Provincial Project for Outcome Assessment in Coronary Heart Disease registry. Am Heart J. 2015;169:833-40. doi:10.1016/j.ahj.2015.02.022.
15. Garcia S, Sandoval Y, Roukoz H, et al. Outcomes after complete versus incomplete revascularization of patients with multivessel coronary artery disease: a meta-analysis of 89883 patients enrolled in randomized clinical trials and observational studies. J Am Coll Cardiol. 2013;62:1421-31. doi:10.1016/j.jacc.2013.05.033.
16. Vechersky YY, Andreev SL, Zatolokin VV. Long-Term Patency Arterial Grafts Used For Coronary Artery Bypass Grafting by Angiographic Assessment. Siberian Medical Journal. 2013;25:43-9. (In Russ.)
17. Frolov AV, Zagorodnikov NI. Cardioprotective role of arterial conduits. Cardiological Bulletin. 2019;14:18-22. (In Russ.) doi:10.17116/Cardiobulletin20191401118.
Supplementary files
Review
For citations:
Zatolokin V.V., Vechersky Yu.Yu., Manvelyan D.V., Kozlov B.N. Role of dihydropyridine calcium channel blockers in coronary bypass surgery using the radial artery graft. Russian Journal of Cardiology. 2022;27(8):4744. (In Russ.) https://doi.org/10.15829/1560-4071-2022-4744